Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Public ClinicalTrials.gov record NCT02992132. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy of pimavanserin compared with placebo in treatment of agitation and aggression after 12 weeks of treatment
Study identification
- NCT ID
- NCT02992132
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 111 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2016
- Primary completion
- Jan 24, 2018
- Completion
- Feb 15, 2018
- Last update posted
- Mar 27, 2019
2016 – 2018
United States locations
- U.S. sites
- 33
- U.S. states
- 20
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Costa Mesa | California | 92626 | — |
| Not listed | Fresno | California | 93710 | — |
| Not listed | Fullerton | California | 92835 | — |
| Not listed | Los Angeles | California | 90073 | — |
| Not listed | Pasadena | California | 91105 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | Danbury | Connecticut | 06810 | — |
| Not listed | Washington D.C. | District of Columbia | 20007 | — |
| Not listed | Boca Raton | Florida | 33486 | — |
| Not listed | Deerfield Beach | Florida | 33064 | — |
| Not listed | Miami | Florida | 33137 | — |
| Not listed | Naples | Florida | 34102 | — |
| Not listed | Atlanta | Georgia | 30322 | — |
| Not listed | Bangor | Maine | 04401 | — |
| Not listed | Quincy | Massachusetts | 02169 | — |
| Not listed | Clinton Township | Michigan | 48035 | — |
| Not listed | Flowood | Mississippi | 39232 | — |
| Not listed | Jackson | Mississippi | 39216 | — |
| Not listed | Eatontown | New Jersey | 07724 | — |
| Not listed | Marlton | New Jersey | 08053 | — |
| Not listed | Toms River | New Jersey | 08755 | — |
| Not listed | Albuquerque | New Mexico | 87131 | — |
| Not listed | Charlotte | North Carolina | 28270 | — |
| Not listed | Oklahoma City | Oklahoma | 73112 | — |
| Not listed | Medford | Oregon | 97504 | — |
| Not listed | Jenkintown | Pennsylvania | 19046 | — |
| Not listed | Norristown | Pennsylvania | 19401 | — |
| Not listed | Willow Grove | Pennsylvania | 19090 | — |
| Not listed | Charleston | South Carolina | 29401 | — |
| Not listed | Nashville | Tennessee | 37212 | — |
| Not listed | DeSoto | Texas | 75115 | — |
| Not listed | Salt Lake City | Utah | 84124 | — |
| Not listed | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02992132, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 27, 2019 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02992132 live on ClinicalTrials.gov.